Hvivo Plc (HVO) Ord 0.1p

Sell:8.60pBuy:8.80pPrice unchangedNo change

Market closed |
Prices delayed by at least 15 minutes
Sell:8.60p
Buy:8.80p
Change:Price unchangedNo change
Deal now
Market closed |
Prices delayed by at least 15 minutes
Sell:8.60p
Buy:8.80p
Change:Price unchangedNo change
Market closed |
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open-
Previous close8.70p
Market cap£59.89m
P/E ratio-
Volume-
Dividend yield2.30%
EMS30000

Company information

hVIVO plc is a United Kingdom-based specialist early-stage drug development contract research organization (CRO) and human challenge trials. The Company delivers end-to-end clinical development services to a diverse and ...

  • LocationUnited Kingdom
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyGBP
  • Shares in issue688.40m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share£0.002
  • Ex-dividend date15 May 2025
  • Payment date11 June 2025

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.